DHEA (3β-hydroxy-androst-5-en-17-one) is a natural steroid prohormone. Despite a lack of information on the effect, DHEA and other prohormones are frequently used as a food supplement by body-builders. DHEA is suspected for growth promoting abuse in cattle as well. Considering the latter, urine samples from a previous exposure study in which calves were exposed to 1 g DHEA per day during 7 days, were used. The calves were divided in three groups: one orally treated, one intramuscularly injected and a control group. The effect of this treatment on the urinary profile of several precursors and metabolites of DHEA was investigated. Urine samples were collected several days before and during the 7 days of administration and were submitted to a clean-up procedure consisting of a separation of the different conjugates (free, glucuronidated and sulphated forms) of each compound on a SAX column (Varian). An LC-MS/MS method was developed for the detection and quantification of several metabolites of the pathway of DHEA including 17α-and 17β-testosterone, 4-androstenedione, 5-androstenediol, pregnenolone and hydroxypregnenolone. Elevated levels of DHEA, 5-androstenediol and 17α-testosterone were observed in the free and sulphated fraction of the urine of the treated calves, thus indicating that the administered DHEA is metabolized mainly by the ∆ 5 -pathway with 5-androstenediol as the intermediate.
INTRODUCTION
The EC Directive 96/22 states that substances with hormonal activity are prohibited in cattle fattening [1] . Monitoring programs are required to live up to this Directive, thus requiring experience in analyzing feed, urine and tissue samples for screening and confirmation of hormone residues [2] . In addition, knowledge about absorption, biotransformation and excretion kinetics of illegally administered hormonal substances, as well as levels of endogenous hormones in livestock, is another requisite [1;3] . Besides steroids, there is a tendency in the livestock production towards misuse of feed supplements and preparations containing prohormones. The action of these prohormones is based on the conversion into more active hormones in target organs, after administration and uptake in the blood circulation. This may lead to anabolic action and subsequently improved lean/fat ratios in farm animals [4;5] .
DHEA (Dehydroepiandrosterone, 3β-hydroxy-androst-5-en-17-one) is a natural steroid prohormone and is a key intermediate in the biosynthesis of biologically potent androgens and estrogens [6;7] . Endogenous steroids can be produced by the means of two alternative pathways, the ∆ 4 -and the ∆ 5 -pathway, corresponding to the metabolisation of cholesterol to pregnenolone and progesterone as the primary precursors and respectively 4-androstenedione and DHEA as their intermediates. Starting from DHEA, the conversion to 17β-testosterone (figure 1) can be catalyzed by hydroxysteroid dehydrogenases (HSDs) over 4-androstenedione (mainly in the gonads) or 5-androstenediol (mainly in the adrenal gland) [5;8-10] . However, abuse of DHEA, and also other prohormones, has been hard to prove due to the incomplete understanding of the DHEA metabolism as well as intra-and interindividual variability in urinary steroid excretion [4;11] . Recently, a metabolomics based screening strategy has been conducted by Rijk et al. [12] in which several bovines where treated with prohormones such as DHEA and pregnenolone. Data were analyzed using multivariate statistics followed by identification of signals differential in urine of DHEAtreated versus control animals. This screening strategy is a useful tool to trace abuse with prohormones like DHEA and pregnenolone. However the concentration levels of this prohormones remains unknown and therefore a targeted analysis after this untargeted approach can be an added value.
The aim of our study was to focus on the excretion profile of DHEA and its metabolites in calf urine after an oral and intramuscular administration of DHEA. It was possible with our quantitative method to get an idea of the concentration levels of DHEA and several of its metabolites after intake of DHEA, which was unknown in calves until now. Naturally, DHEA is mainly present in blood and urine of older animals in its sulphated form and to a much lesser extent in its free form or as a glucuronide conjugate [11] . The sample clean-up was set up such that each form, i.e. free, sulphated or glucuronidated form of DHEA and its metabolites could be investigated.
MATERIALS AND METHODS

Experimental Protocol
Urine samples were collected according to the study design presented in figure 2 . Eight calves ranging in age from 6 till 10 months were used in this study, aiming to simulate the actual practice. These real-life bovines were housed in stables and normally fed. At two different time intervals several calves were allocated to a group and received either an oral treatment with DHEA or an intramuscular treatment with DHEA, while others served as controls.
Treated calves were administered with 1 g of DHEA, orally or intramuscularly, every day for seven days. In the first period (june 2005), 1 calf was treated orally, 1 intramuscularly and 3 served as controls and did not receive any DHEA supplementation. In the second period (december 2006), 1 calf was treated orally, 1 intramuscularly and 1 served as a control.
DHEA treatment was performed in the morning and urine sampling in the late afternoon for the first period and just before the next treatment in the second group (period 2). Urine samples were collected several days before treatment (5 days before treatment in period 1 and on days -20 and -5 before treatment in period 2) and during 7 days of administration in both periods. This study was undertaken after approval by the Ethical Committee of Ghent University. Samples were collected and frozen at -20°C until analysis.
Reagents and chemicals
Methanol was high-performance liquid chromatography grade and obtained from VWR 
Materials and apparatus
Octadecyl (C 18 ) (6 mL, 500 mg) and aminopropyl (NH 2 ) (3 mL, 500 mg) SPE columns were purchased from Grace Discovery Sciences (Lokeren, Belgium). The C 18 -SPE column was conditioned by passing through 2 x 5 mL of methanol followed by 2 x 5 mL of water. The with the cone voltages and collision energies, is given in table 2. Capillary voltage was set at 4.8 kV, the extractor at 3 V and high-purity nitrogen was used as spray gas. Source and desolvation temperatures were set at 150°C and 350°C respectively.
Separation of the free, glucuronide and sulphate fractions
The sample clean-up was based on the method descibed by Van Poucke et al. for the fractionation of free and conjugated steroids for the detection of boldenone metabolites in calf urine [13] . In short, the procedure is as follows: the pH of 10 mL of the urine samples were adjusted to 4.6 with 3 M acetate buffer (pH 4.6) and applied onto C 18 cartridges. After washing with 2 x 5 mL of water and 2 x 5 mL 10% methanol, a preconditioned SAX column was placed under the C 18 column. The free and conjugated fractions were then eluted with 2 x 5 mL methanol where only the the conjugated fractions were retained and the free form was collected. Next, the glucuronide fraction was eluted from the SAX column with 10 mL FA (0.5 M) in methanol. In the third step, a preconditioned C 18 cartridge was placed underneath the SAX column and the sulphate fraction was eluted from the SAX column with 10 mL triethylamine (0.5 M) in water and was trapped onto the C 18 column. After washing the C 18 column with 2 x 5 mL water, the suphate fraction was finally eluted with 5 mL of methanol.
All fractions were then evaporated to dryness at 40°C under nitrogen.
Hydrolysis
Next, the glucuronide and sulphate fractions were submitted to an hydrolysis step. The enzymatic hydrolysis of the glucuronide fractions was achieved by adding 5 mL of a 0.2 M acetate buffer (pH 4.6) and 25 µL of a tenfold dilution of Helix Pomatia juice in water. The samples were then kept for 2 h at 60°C. For the hydrolysis of the sulphate fraction, the dried residue was dissolved in 5 mL of a solvolysis solution consisting of 1 M lithium chloride / hydrochloric acid. This samples were kept 1 h at 80°C and afterwards 15 mL of water was added and the samples were centrifuged at 2800 g.
Final sample clean-up
The dried residue of the free fraction was redissolved in 10 mL of water. The free fractions and the supernatant of the glucuronide and sulphate fractions were then applied onto a C 18
column. Afer washing with 2 x 5 mL of water and 2 x 5 mL 10% methanol, the column was dried and placed underneath a preconditioned NH 2 column. The columns were then eluted with 5 mL of ethyl acetate. The eluates were evaporated to dryness at 40°C under nitrogen.
The dried residues were each dissolved in 150 µL of mobile phase (methanol/water/FA (60/39.7/0.3)).
Quantification and identification
Matrix calibration curves were performed daily by analyzing 5 blank urines (10 mL) spiked at Several urines were analyzed on two different time intervals. The concentrations of all target compounds in the entire concentration range differed maximally 30%.
Data analysis
All results are reported as the mean ± SE (standard deviation) and the median. Data were analyzed using a two-way analysis of variance. Non-parametric data were analyzed by means of Kruskal-Wallis test. When significant effects were revealed or only two groups were examined, an independent t-test or Mann-Whitney test taking account of the Bonferroni correction was used to locate the pair wise differences between groups. Spearman's correlations coefficients were calculated to determine significant correlations between the concentration of the several hormones and the day of urine collection. P < 0.05 was considered as statistically significant.
All calculations were executed in Excel ® or in SPSS ® .
RESULTS AND DISCUSSION
Urinary concentrations of DHEA, AED, 5-Andro, α-T, β-T, Preg and OH-Preg in calves were investigated before starting the treatment and during the DHEA treatment. Levels of the precursors Preg and OH-preg in urines during the entire study were found too low to be confirmed and/or quantified. Therefore it is not possible to draw any conclusion about the levels of Preg and OH-Preg before and after treatment with DHEA and as a consequence the data and statistical processing of these compounds are left out of the discussion. Table 3a shows the mean basal concentrations, the median, minimum and maximum value of the target analytes in the urines from the 5 calves of group 1 (June 2005) before starting the treatment.
This was evaluated in order to show whether the treated calves were not calves which already excreted higher concentrations of these hormones and which statistically did not differ from the control calves at the beginning of the treatment. No significant differences were observed in group 1 in the baseline levels of DHEA and its metabolites 5-Andro, α-T, β-T, AED in the free or sulphated form. Group 2 (December 2006) did not yield enough data to prove this statistically. However, the assumption was made that there was also no significant difference in the basal urinary concentrations of these hormones in the 3 calves of group 2, shown in table 3b. Despite the large inter-and intravariability in all hormones in free and sulphated form, initial basal levels were not statistically different and within the normal range.
Therefore, the biological variability is not expected to give any problems when comparing the control group with the treatment group during the study. However, when comparing the mean concentrations and corresponding standard deviations of the two groups (table 3a and 3b), slightly higher concentrations of the sulphated form of 5-Andro, α-T and β-T were observed in group 2. This was expected as the age of the calves differs between the two groups and was part of the general idea of using real-life bovine animals. In group 1 the calves were only 6 months old in contrast with the calves of group 2 that were already 9 till 10 months of age.
These observed differences were checked statistically. Therefore basal urinary concentrations of all the hormones in free and sulphated form before treatment were compared between the group 1 and 2. A statistically significant difference in the levels of sulphated α-T (p=0.027) and β-T (p=0.012) was found between group 1 and 2. These results, higher levels of α-T and β-T in group 2, are in accordance with results earlier obtained by analyzing urine samples of calves and young bovines [3;15] . These studies pointed out that when the two isomers of testosterone (α and β) were followed, α-T was the first that appeared in the urine of calves.
When the calves got older and turned into young bovines, the concentration of α-T increased and low amounts of β-T appeared.
In a next step baseline levels of the control animals before and during the treatment were compared. Because of the proven differences between the two groups for α-T and β-T, data of α-T and β-T obtained in group 2 where excluded when comparing the baseline levels of the control animals before and during treatment. Table 4 figure 3D ) and no statistical difference between the orally and intramuscularly treated group for these sulphated conjugates could be detected. Figure 4 summarizes the results of the concentrations of DHEA and its metabolites in the free form of the three different treatments: control group (control), orally treated group (oral) and intramuscularly treated group (IM). The comparison of the concentrations of DHEA and its metabolites of the different groups in the free form differed slightly from the sulphated form.
Here there was a statistically significant difference between the control group and the orally treated group for DHEA (p=0.000) and α-T (p=0.000), and when comparing the control group with the intramuscularly treated group for DHEA (p=0.000), 5-Andro (p=0.001) and α-T not show this correlation. We have no straightforward explanation, but the calf in group 2 was treated in the winter in contrast with the calf in group 1 that received the treatment in the summertime. Therefore the second calf had more adipose tissue, possibly retaining the DHEA longer and releasing more DHEA after a few days, resulting in higher DHEAS concentration in the urine. A positive correlation, but to a lesser extent, was also seen in this IM treated calf of group 2 for 5-Andro (p=0.05 and R=0.75). In contrast with the intramuscularly treated group, the orally treated group showed a steady-state condition.
CONCLUSIONS
Sulphates, glucuronides and free forms were analyzed separately in order to gather information about the distribution of DHEA and its metabolites over these three forms. In general our results show that DHEAS constitute the largest proportion of urinary levels of DHEA. This was also found in humans, where DHEA is rapidly converted into DHEAS, which can be converted back to DHEA by peripheral sulphatases [17] . In this way DHEAS serves as a large precursor reservoir for the production of androgens and estrogens in nonreproductive tissues [18] . The free form of DHEA was present to a much lesser extent than the sulphated form and DHEA-glucuronides were negligible and in most cases not quantifiable because concentrations were below the limit of detection No elevated levels of sulphated or free β-T were observed after administered DHEA, either oral or IM. This seems strange, as levels of α-T were increasing, while α-T is considered as the main metabolite of β-T from the action of 3β-hydroxysteroid dehydrogenase. However, these results are in accordance with the findings obtained by administration of DHEA to the gelding and the mare where there was a high conversion to 5-Andro and a much lower conversion to α-and β-T [19] . These results are also confirmed in humans where ingested DHEA was rapidly metabolized to 5-Andro [20] . 
